Taibang Biological Group

About:

Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products.

Website: http://en.chinabiologic.com/

Top Investors: Abu Dhabi Investment Authority, Hillhouse Investment, GIC, CITIC Capital Holdings, IDG Capital

Description:

Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products. The company's core business includes the development, manufacture, and sale of plasma-derived products and other biopharmaceutical products.

Total Funding Amount:

$900M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2002-01-01

Contact Email:

ir(AT)chinabiologic.com

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2022-08-02

IPO Status:

Delisted

© 2025 bioDAO.ai